CLASS II Drug recall · Reported 18 Mar 2020 · FDA Enforcement Report

Vancomycin 900MG in 0.9% NACL Injectable recalled

Redline Pharmacy Solutions is recalling Vancomycin 900MG in 0.9% NACL Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive, distributed in Nebraska. The recall was initiated on 24 Feb 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 02242020@8

Quantity recalled3 doses

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-1010-2020
FDA event ID: 85081
Recalling firm: Redline Pharmacy Solutions, Hastings, NE
Classification: Class II
Status: Terminated
Recall initiated: 24 Feb 2020
FDA classified: 12 Mar 2020
Reported: 18 Mar 2020
Type: Voluntary: Firm initiated
Customers notified by: Telephone
Reason category: Other Reasons
Drug class: Antibiotics

Timeline

24 Feb 2020	Recall initiated by company
12 Mar 2020	Classified by FDA	+17 days
18 Mar 2020	Published in enforcement report	+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack Of Processing Controls

Product as listed by the FDA

Vancomycin 900MG in 100ML 0.9% NACL Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Where it was distributed

Sold to patients in Nebraska

Nebraska

Questions about this recall

Why was it recalled?

Lack Of Processing Controls

Which lots are affected?

Lot 02242020@8

Where was it sold?

Sold to patients in Nebraska

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

5 other products · FDA event 85081

This product is part of a recall event; the main page for the event is Daptomycin, 500MG in 0.9% NACL Injectable Redline Specialty recalled.

Reported	Class	Recall	Company	Reason	Where
18 Mar 2020	CLASS II	Daptomycin, 500MG in 0.9% NACL Injectable Redline Specialty recalled	Redline Pharmacy Solutions	Other	NE
18 Mar 2020	CLASS II	Morphine Sulfate, 20 mg/mL intrathecal per syringe recalled	Redline Pharmacy Solutions	Other	NE
18 Mar 2020	CLASS II	Morphine Sulfate (Mitigo), 5 mg/mL intrathecal per syringe recalled	Redline Pharmacy Solutions	Other	NE
18 Mar 2020	CLASS II	Acetylcysteine Ophthalmic 10% Solution per dropper recalled	Redline Pharmacy Solutions	Other	NE
18 Mar 2020	CLASS II	Ertapenem in 0.9% NACL 1GM Injectable recalled	Redline Pharmacy Solutions	Other	NE

Reported	Class	Recall	Company	Reason	Where
18 Mar 2020Drug	CLASS II	Ertapenem in 0.9% NACL 1GM Injectable recalled	Redline Pharmacy Solutions	Other	NE
18 Mar 2020Drug	CLASS II	Acetylcysteine Ophthalmic 10% Solution per dropper recalled	Redline Pharmacy Solutions	Other	NE
18 Mar 2020Drug	CLASS II	Morphine Sulfate (Mitigo), 5 mg/mL intrathecal per syringe recalled	Redline Pharmacy Solutions	Other	NE
18 Mar 2020Drug	CLASS II	Morphine Sulfate, 20 mg/mL intrathecal per syringe recalled	Redline Pharmacy Solutions	Other	NE
18 Mar 2020Drug	CLASS II	Daptomycin, 500MG in 0.9% NACL Injectable Redline Specialty recalled	Redline Pharmacy Solutions	Other	NE

Other Vancomycin recalls

All 65

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	Vancomycin Injection, USP in 5% Dextrose per (5 mg/mL) recalledVancomycin Hydrochloride	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
9 Sep 2026Drug	CLASS II	Vancomycin Injection, USP, in 0.9% Sodium Chloride recalledVancomycin Hydrochloride	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide
24 Apr 2024Drug	CLASS I	Vancomycin Hydrochloride for Oral Solution, USP, 250 mg recalledVancomycin Hydrochloride	Amneal Pharmaceuticals of New York	Potency & Assay	Nationwide
25 Oct 2023Drug	CLASS II	Vancomycin 1 MG/ Solution for Intraocular Injection Single Dose Vial recalled	Pine Pharmaceuticals	Sterility	Nationwide
9 Aug 2023Drug	CLASS II	vancomycin 750 mg/ added to 0.9% Sodium Chloride, (3 mg/mL), IV recalled	Central Admixture Pharmacy Services	Sterility	Nationwide